TRS Earnings

TRS reported its earnings on 2026-02-26, showcasing a revenue of against an estimate of 230.02M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.41 by 0%. The stock experienced a 3.12% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following TRS's earnings announcement on 2026-02-26, the stock price moved by 3.12% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, TRS's stock price tends to shift by an average of 0.68% in the 10 days leading up to earnings and 1.05% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate TRS's annual revenue to reach 209.05M, while the EPS is projected at 0.39. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between TRS's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, TRS's stock price typically moves by 0.68% in the 10 days before its earnings and 1.05% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.39 and revenue of 209.05M.

The earnings report shows strong growth in the Aerospace segment, improved margins due to cost-saving initiatives, and a positive outlook for 2025 with increased guidance. The Q&A revealed management's confidence in margin improvement and potential growth in life sciences and other segments. While there were some unclear responses regarding share repurchases and acquisitions, the overall sentiment is positive, especially with the raised EPS and sales growth guidance. Given the market cap of $1.03 billion, the stock is likely to react positively, potentially within the 2% to 8% range.